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A dysgerminoma is a very rare and malignant
tumour originating from the ovarian primordial
germ cells. Germ cell tumours account for 2.6% of
all ovarian malignant tumours and about 70% of
cases of ovarian cancer in the early decades of life,
and are found very rarely thereafter.1 2
The authors describe the case of a previous
healthy 22-year-old woman, nulligravida, with a
history of right ovarian dysgerminoma FIGO
(International Federation of Gynaecology and
Obstetrics) stage IC (conservative fertility surgery
with full staging—right salpingo-oophorectomy,
conservation of the uterus and left adnexae with
positive peritoneal lavage cytology for malignant
cells, without residual neoplasia and no nodal
metastases, and negative left ovary and peritoneal
biopsies—and three cycles of adjuvant chemother-
apy with the bleomycin/etoposide/cisplatin scheme,
had been performed). Five months after surgical
staging and chemotherapy treatment, the patient
was admitted in the emergency ward, because of
pain in the left iliac fossa, with a bulky pelvic mass
Figure 1 Ultrasound findings—complex cystic left
adnexal mass with large transverse diameter of 77.2 mm
causing mass effect on the bladder (represented on the
left top of the image). There were no suspicious findings
on Doppler.
Learning points
▸ Ovarian germ cell tumours often present with
pain and/or abdominal mass and are usually
unilateral, except dysgerminomas, which in
15% of cases are bilateral. Seventy per cent of
cases are diagnosed in FIGO (International
Federation of Gynaecology and Obstetrics)
stage I. Staging is surgical, according to the
FIGO staging scheme, common to epithelial
tumours. The pelvic recurrence in this type of
tumour can occur in 20% of patients, usually
in the first 24 months after therapy.1–3
▸ Unilateral salpingo-oophorectomy is a surgical
procedure with minimal tumour resection in
this type of tumour and is indicated in young
women, with the intention of preserving
fertility if the uterus and contralateral ovary do
not present with abnormalities.2
▸ The current standard treatment of ovarian
cancer consists of primary debulking surgery
followed by adjuvant chemotherapy. Pelvic and
para-aortic lymphadenectomy forms an
integral part of the stage surgery and may be
associated with intraoperative and
postoperative complications (one of the most
common postoperative complication is the
development of a lymphocoele). So a
postoperative lymphocoele should always be
included in the differential diagnostic approach
to postsurgical pelvic masses appearing after
staging ovarian cancer (vs pelvic tumour
recurrence or, as in this specific case,
co-existing primary bilateral dysgerminoma,
with the need for intraoperative evaluation of
the contralateral ovary preserved in the
primary surgery being imperative).3 Treatment
of asymptomatic lymphocoeles is conservative,
with these ending up reabsorbed. In the case
of bulky infected lymphocoeles, or those
associated with pain and compression of
adjacent organs, draining, if possible
percutaneously, is recommended.Figure 2 Pelvic CT findings—large cystic left adnexal
mass (large anteroposterior diameter of 85.6 mm).
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bulging on the left vaginal fornix in the gynaecological examin-
ation. Pelvic ultrasound showed a suspected 100.4×77.2 mm
left cystic adnexal mass with multiple and small septa (figure 1),
confirmed by pelvic CT (figure 2) and MRI (figure 3). With sup-
posed pelvic recurrence, the patient underwent laparotomy and
a large lymphocoele was found and drained. The left ovary had
a normal macroscopic appearance.
The follow-up period for 5 years did not reveal any clinical,
analytical (the tumour markers—β-human chorionic gonado-
tropin, α-fetoprotein, lactate dehydrogenase—were always nega-
tive since the initial diagnosis of dysgerminoma) or imaging
abnormalities.
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Figure 3 Pelvic MR findings
confirming the results of the pelvic
ultrasound and CT scan with the
differential diagnosis of possible
postoperative lymphocoele (A—
para-sagittal T2-weighted image
showing large cystic left adnexal
lesion/lymphocoele containing debris
(larger diameter of 98.1 mm); B—axial
T1-weighted image showing large
cystic thick-walled left adnexal tumour/
lymphocoele causing a mass effect on
the bladder (large anteroposterior
diameter of 89.1 mm)).
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